Hidradenitis suppurativa (HS) compromises a multifactorial pathogenesis with a largely unclear aetiology.
Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a serious, debilitating, chronic inflammatory skin disease.
NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa
Which treatments have been shown to be effective in randomized clinical trials (RCTs) for hidradenitis suppurativa (HS) in adults?
Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis.
The true incidence of hidradenitis suppurativa (HS) is unknown.
Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States
The true prevalence of hidradenitis suppurativa (HS) is unknown.
Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study
Hidradenitis suppurativa (HS) is often associated with inflammatory bowel disease (IBD; Crohn's disease or ulcerative colitis). However, the prevalence of IBD in HS patients is unknown.
Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas.
The Hedgehog (Hh) pathway is critical for cell differentiation, tissue polarity, and stem cell maintenance during embryonic development, but is silent in adult tissues under normal conditions.
Several guidelines for urticaria and angioedema have been published in Europe and United States since 1997.
Appropriate management of urticaria depends on the correct evaluation of clinical patterns and causes where these can be identified.